Price (delayed)
$18.78
Market cap
$1.37B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.79
Enterprise value
$1.38B
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications
There are no recent dividends present for SDGR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.